CTA is pleased to support the recent publication by Hitchen N, Shahnam A, Manoharan S et al, reviewing trends in Phase 1 oncology clinical trials across Australia. This paper [...]
With both artificial intelligence and cybersecurity now squarely in the public eye, Dr. Dishan Herath brings a new perspective as the newest member of the Cancer Trials Australia Board. [...]
CTA’s June 2024 team development day was a Spanish Cooking class. Staff were split into four groups, working together to prepare the first part of the menu, making delicious [...]
I am pleased to share with you our 2023 Annual Report, released at our recent Annual General Meeting on 22 May, 2024. Please click here to access the report. The 2023 [...]
In mid-November, CTA was pleased to offer a Stress and Resilience Workshop for all staff, delivered by Bailey Opie, a Performance Psychologist at The Mind Room. We were extremely [...]
In late November CTA was pleased to host our second Developmental Therapeutics Update Dinner meeting for 2023, presented with the generous support of the Series sponsors, namely Amgen, AstraZeneca, [...]
In late October CTA was pleased to host our Annual Research Managers’ Day, a site driven, in-person forum that continues to grow in popularity each year. In 2023 we [...]
I am pleased to share with you our 2022 Annual Report, released at our recent Annual General Meeting on 24 May, 2023. This Annual Report also takes the opportunity [...]
I am pleased to share with you the 2021 Cancer Trials Australia Annual Report, released at our recent Annual General Meeting on 18 May, 2022. Please click here to access [...]
Welcoming Associate Professor Jayesh Desai as the Incoming Chairperson of the Cancer Trials Australia Board of Directors As his six-year tenure draws to a conclusion, outgoing Cancer Trials [...]
